Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06862557 · ClinicalTrials.gov registry record · NA
Pulsed Electromagnetic Field Treatment With Dementia Patients
A NA study of Alzheimers Disease and Vascular Dementia, sponsored by Herrick Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT06862557 is a NA study of Alzheimers Disease and Vascular Dementia that is actively recruiting participants, run by Herrick Medical. The registered enrollment target is 48 participants, below the 4,061-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06862557, a NA study of Alzheimers Disease and Vascular Dementia, is actively recruiting participants, sponsored by Herrick Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
An open label pilot study in mild to moderate AD/ADRD patients to assess the effects of treatment with ECHS AD/ADRD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end point is the The Alzheimer's Disease Assessment Scale-Cognitive Subscale. Participants will be followed-up for 9 months post-treatment.
Conditions Studied
Interventions
- DEVICE ECHS AD Device
Study Locations (1)
Florida
- University of Miami - Boca Raton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06862557
The ClinicalTrials.gov registry entry for NCT06862557 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,061-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (99% lower). The listed sponsor is Herrick Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Alzheimers Disease appearing as the primary indexed condition, and to 1 intervention - of which ECHS AD Device is the first listed.
NCT06862557 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06862557 about?
NCT06862557 is a clinical study titled "Pulsed Electromagnetic Field Treatment With Dementia Patients". An open label pilot study in mild to moderate AD/ADRD patients to assess the effects of treatment with ECHS AD/ADRD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over ...
What is the current status of trial NCT06862557?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2025-04-01. Estimated completion is 2026-09-30.
What conditions does trial NCT06862557 study?
This clinical trial studies the following conditions: Alzheimers Disease, Vascular Dementia, Lewy Body Dementia.
What interventions are being tested in trial NCT06862557?
The interventions under investigation include: ECHS AD Device (DEVICE).
Who is sponsoring clinical trial NCT06862557?
This trial is sponsored by Herrick Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06862557 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimers Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
University of Central Florida Music Study
RECRUITING · NA
-
Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease
RECRUITING · NA
-
Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study
RECRUITING · NA
-
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
RECRUITING · NA
-
A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
RECRUITING · NA
-
Tango for Alzheimer's Disease Patients' Caregivers
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.